Aging, Melatonin, and the Pro- and Anti-Inflammatory Networks
Open accessThe DOI matches its Crossref record; 399 of the 412 references it cites were found in a registry or an index.
Abstract
Aging and various age-related diseases are associated with reductions in melatonin secretion, proinflammatory changes in the immune system, a deteriorating circadian system, and reductions in sirtuin-1 (SIRT1) activity. In non-tumor cells, several effects of melatonin are abolished by inhibiting SIRT1, indicating mediation by SIRT1. Melatonin is, in addition to its circadian and antioxidant roles, an immune stimulatory agent. However, it can act as either a pro- or anti-inflammatory regulator in a context-dependent way. Melatonin can stimulate the release of proinflammatory cytokines and other mediators, but also, under different conditions, it can suppress inflammation-promoting processes such as NO release, activation of cyclooxygenase-2, inflammasome NLRP3, gasdermin D, toll-like receptor-4 and mTOR signaling, and cytokine release by SASP (senescence-associated secretory phenotype), and amyloid-β toxicity. It also activates processes in an anti-inflammatory network, in which SIRT1 activation, upregulation of Nrf2 and downregulation of NF-κB, and release of the anti-inflammatory cytokines IL-4 and IL-10 are involved. A perhaps crucial action may be the promotion of macrophage or microglia polarization in favor of the anti-inflammatory phenotype M2. In addition, many factors of the pro- and anti-inflammatory networks are subject to regulation by microRNAs that either target mRNAs of the respective factors or upregulate them by targeting mRNAs of their inhibitor proteins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Inducing effect of melatonin on macrophage and microglia polarization in favor of the anti-inflammatory phenotype M2 is well known (59).”
From Melatonin Attenuates LPS-Induced Acute Depressive-Like Behaviors and Microglial NLRP3 Inflammasome Activation Through the SIRT1/Nrf2 Pathway (2019) · cites this paper as [59]
In the citing paper
“Its antioxidant and anti-inflammatory activities are exerted through the suppression of cyclooxygenase 2, NLRP3 inflammasome, gasdermin D, TLR-4, NF-kB, and NO release, as well as the concomitant activation of SIRT1 and Nrf2 free radical scavenging network [452].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [452]
In the citing paper
“As a reduction in melatonin secretion has been observed during aging [452], several studies have explored the role of this hormone in counteracting cellular senescence [451].”
From The Role of Antioxidants in the Interplay between Oxidative Stress and Senescence (2022) · cites this paper as [452]
In the citing paper
“In vitro and in vivo studies demonstrate melatonin’s protective ability against mitochondria-mediated injury with hypertension and obesity, suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [33]
In the citing paper
“suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
From Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements (2022) · cites this paper as [33]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
11 retracted
Zou, P., Liu, X., Li, G., & Wang, Y. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.8241 · Cited by 130
RetractedShi, D., Xiao, X., Wang, J., Liu, L., Chen, W., Fu, L., Xie, F., Huang, W., & Deng, W. (2012) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2012.00982.x · Cited by 101
RetractedChuffa, L. G. A., Fioruci-Fontanelli, B. A., Mendes, L. O., Ferreira Seiva, F. R., Martinez, M., Fávaro, W. J., Domeniconi, R. F., Pinheiro, P. F., Delazari dos Santos, L., & Martinez, F. E. (2015) · BMC Cancer · doi:10.1186/s12885-015-1032-4 · Cited by 100 · cited 2×
“No effects were found in a single study on TLR2 [144], whereas inhibition of TLR3 was reported [145,146].”
BackgroundRetractedFan, T., Pi, H., Li, M., Ren, Z., He, Z., Zhu, F., Li, T. X., Tu, M., Xie, J., Liu, M., et al. (2017) · Journal of Pineal Research · doi:10.1111/jpi.12457 · Cited by 93
RetractedSu, Z., Zhang, P., Yu, Y., Lu, H., Liu, Y., Ni, P., Su, X., Wang, D., Liu, Y., Wang, J., et al. (2016) · Scientific Reports · doi:10.1038/srep21884 · Cited by 80
RetractedZhang, S., Jiang, L., Che, F., Lu, Y., Xie, Z., & Wang, H. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.062 · Cited by 74
RetractedYang, W., Kang, X., Qin, N., Li, F., Jin, X., Ma, Z., Qian, Z., & Wu, S. (2017) · Steroids · doi:10.1016/j.steroids.2017.08.005 · Cited by 28
RetractedWu, C., Huang, Y. X., Pei, Z., Xi, X., & Zhu, G. (2018) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2018.04.019 · Cited by 26
RetractedMiR-125b Inhibits LPS-Induced Inflammatory Injury via Targeting MIP-1α in Chondrogenic Cell ATDC5
Jia, J., Wang, J., Zhang, J., Cui, M., Sun, X., Li, Q., & Zhao, B. (2018) · Cellular Physiology and Biochemistry · doi:10.1159/000488178 · Cited by 25
RetractedBu, P., Luo, C., He, Q., Yang, P., Li, X., & Xu, D. (2017) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2017.4595 · Cited by 23
Retracted
Research works printed but not linked: 1
- Hardeland R. Opposite effects of melatonin in different systems and under different conditions Curr. Top. Biochem. Res. 2016 17 57 69
Cited by
COVID-19: Melatonin as a potential adjuvant treatment
Zhang, R., Wang, X., Ni, L., Di, X., Ma, B., Niu, S., Liu, C., & Reiter, R. J. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117583 · Cited by 619
“There may be, however, some concerns about the potential pro-inflammatory actions of melatonin when used in very high doses or under suppressed immune conditions where it may induce an increase production of pro-inflammatory cytokines, IL-1β, IL-2, IL-6, IL-12, TNF-α, and IFN-γ [35] .”
BackgroundInflammaging and Oxidative Stress in Human Diseases: From Molecular Mechanisms to Novel Treatments
Zuo, L., Prather, E. R., Stetskiv, M., Garrison, D. E., Meade, J. R., Peace, T. I., & Zhou, T. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184472 · Cited by 539
“Melatonin, apart from its circadian roles, is another crucial regulator that can suppress NF-κB activity (Figure 3A) [160].”
BackgroundArioz, B. I., Tastan, B., Tarakcioglu, E., Tufekci, K. U., Olcum, M., Ersoy, N., Bagriyanik, A., Genc, K., & Genc, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01511 · Cited by 516
“Inducing effect of melatonin on macrophage and microglia polarization in favor of the anti-inflammatory phenotype M2 is well known (59).”
BackgroundNeuroinflammation in Alzheimer’s Disease
Onyango, I. G., Jauregui, G. V., Čarná, M., Bennett, J. P., & Stokin, G. B. (2021) · Biomedicines · doi:10.3390/biomedicines9050524 · Cited by 330
“polarization towards an M2 phenotype [452].”
BackgroundInflammaging: Implications in Sarcopenia
Antuña, E., Cachán-Vega, C., Bermejo-Millo, J. C., Potes, Y., Caballero, B., Vega-Naredo, I., Coto-Montes, A., & Garcia-Gonzalez, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms232315039 · Cited by 215
Secomandi, L., Borghesan, M., Velarde, M., & Demaria, M. (2022) · Human Reproduction Update · doi:10.1093/humupd/dmab038 · Cited by 208
“As an immunomodulator, melatonin can either provoke the release of pro-inflammatory mediators or, in alternative circumstances, mitigate inflammation through SIRT1, Nrf2 and NF-jB regulation (Hardeland, 2019).”
Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176
“In vitro and in vivo studies demonstrate melatonin’s protective ability against mitochondria-mediated injury with hypertension and obesity, suggesting that dietary supplementation with exogenous melatonin in later years may be an effective therapeutic intervention for such age-related conditions [33].”
BackgroundZhang, G.-Z., Deng, Y.-J., Xie, Q.-Q., Ren, E.-H., Ma, Z.-J., He, X.-G., Gao, Y.-C., & Kang, X.-W. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.04.016 · Cited by 158
Ionizing Radiation as a Source of Oxidative Stress—The Protective Role of Melatonin and Vitamin D
Nuszkiewicz, J., Woźniak, A., & Szewczyk-Golec, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165804 · Cited by 156
Immunosenescence: signaling pathways, diseases and therapeutic targets
Fu, Y., Wang, B., Alu, A., Hong, W., Hong, L., He, X., Shi, H., Cheng, P., & Yang, X. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02371-z · Cited by 187
“46,47 These effects are mediated by SIRT1 pathway activation, which optimizes mitochondrial function and autophagy, and by miRNA-dependent regulation (e.g., miR-146a targeting Nrf2/NF-κ B pathways), although the mechanisms vary across cell types and microenvironments.”
InfluentialThe Role of Antioxidants in the Interplay between Oxidative Stress and Senescence
Varesi, A., Chirumbolo, S., Campagnoli, L. I. M., Pierella, E., Piccini, G. B., Carrara, A., Ricevuti, G., Scassellati, C., Bonvicini, C., & Pascale, A. (2022) · Antioxidants · doi:10.3390/antiox11071224 · Cited by 145
“Its antioxidant and anti-inflammatory activities are exerted through the suppression of cyclooxygenase 2, NLRP3 inflammasome, gasdermin D, TLR-4, NF-kB, and NO release, as well as the concomitant activation of SIRT1 and Nrf2 free radical scavenging network [452].”
BackgroundProtective Role of Melatonin and Its Metabolites in Skin Aging
Bocheva, G., Slominski, R. M., Janjetović, Z., Kim, T., Böhm, M., Steinbrink, K., Reiter, R. J., Kleszczyński, K., & Slominski, A. T. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031238 · Cited by 143
Zheng, Q. Y., Liu, H., Zhang, H., Han, Y., Yuan, J., Wang, T., Gao, Y., & Li, Z. (2023) · Advanced Science · doi:10.1002/advs.202300758 · Cited by 141
Molecular Mechanisms of Melatonin-Mediated Cell Protection and Signaling in Health and Disease
Kopustinskienė, D. M., & Bernatonienė, J. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13020129 · Cited by 141
Beaupre, L. M., Brown, G. M., Gonçalves, V. F., & Kennedy, J. L. (2021) · Translational Psychiatry · doi:10.1038/s41398-021-01464-x · Cited by 140
Anderson, G., & Maes, M. H. J. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620666200131094445 · Cited by 121
Impact of Melatonin on Skeletal Muscle and Exercise
Stacchiotti, A., Favero, G., & Rodella, L. F. (2020) · Cells · doi:10.3390/cells9020288 · Cited by 102
Targeting Keap1/Nrf2/ARE signaling pathway in multiple sclerosis
Michaličková, D., Hrnčíř, T., Canová, N. K., & Slanař, O. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.172973 · Cited by 102
Kong, F.-Q., Zhao, S.-J., Sun, P., Liu, H., Jie, J., Xu, T., Xu, A.-D., Yang, Y.-Q., Zhu, Y., Chen, J., et al. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01735-2 · Cited by 102
Bushell, W. C., Castle, R., Williams, M. A., Brouwer, K. C., Tanzi, R. E., Chopra, D., & Mills, P. J. (2020) · The Journal of Alternative and Complementary Medicine · doi:10.1089/acm.2020.0177 · Cited by 114
Palagini, L., Geoffroy, P. A., Miniati, M., Perugi, G., Biggio, G., Marazziti, D., & Riemann, D. W. (2021) · CNS Spectrums · doi:10.1017/s1092852921000018 · Cited by 108
“Indeed, considering the plasticity of the brain, a bidirectional nature of neuroprogression also exist and substantial plasticity and remodeling may also occur after treatments.44 Similarly, it is plausible that circadian-oriented interventions targeting the circadian clock might mitigate symptoms, or perhaps even slo…”
BackgroundInfluentialUse of Melatonin in Cancer Treatment: Where Are We?
Wang, L., Wang, C., & Choi, W. S. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073779 · Cited by 109
“Furthermore, melatonin also exerts anti-inflammatory effects by reducing tumor necrosis factor alpha (TNF-α), interleukin-2 (IL-2), and interferon-gamma (IFN-γ) levels and by enhancing the amounts of interleukin-4 (IL-4), interleukin-10 (IL-10), and interleukin-27 (IL-27) [15].”
BackgroundCellular Senescence in the Lung: The Central Role of Senescent Epithelial Cells
Hansel, C., Jendrossek, V., & Klein, D. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21093279 · Cited by 93
“As decisive regulator of SASP, the transcription factor nuclear factor κB (NF-κB) was identified [9,88].”
BackgroundThe circadian clock and inflammation: A new insight
Xu, H., Huang, L., Zhao, J., Chen, S., Liu, J., & Li, G. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.11.011 · Cited by 88
Melatonin and 5-fluorouracil combination chemotherapy: opportunities and efficacy in cancer therapy
Mafi, A., Rezaee, M., Hedayati, N., Hogan, S. D., Reiter, R. J., Aarabi, M. H., & Asemi, Z. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01047-x · Cited by 94
“promoting the production of macrophage M2 that has anti-inflammatory action [21].”
BackgroundMelatonin as the Cornerstone of Neuroimmunoendocrinology
Kvetnoy, I. M., Иванов, Д. О., Mironova, E. S., Evsyukova, I. I., Nasyrov, R. A., Kvetnaia, T. V., & Polyakova, V. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031835 · Cited by 85
“PTEN/AKT [76] Stimulating Anti-inflammation SIRT1 [77] Stimulating Anti-aging TOLLR4 [77] Stimulating Anti-aging, immunomodulation iNO [77] Inhibitory Anti-oxidative NRF-2, CBR1, CLPP, SOD2 [78] Inhibitory Anti-oxidative ANAPC4, HSPA4/Ubiquitination pathway [77] Inhibitory Neuroprotection”
BackgroundLight at night disrupts biological clocks, calendars, and immune function
Walker, W. H., Bumgarner, J. R., Becker‐Krail, D. D., May, L. E., Liu, J. A., & Nelson, R. J. (2021) · Seminars in Immunopathology · doi:10.1007/s00281-021-00899-0 · Cited by 79
Melatonin as an Anti-Aging Therapy for Age-Related Cardiovascular and Neurodegenerative Diseases
Giménez, V. M. M., Heras, N. D. L., Lahera, V., Tresguerres, J. A. F., Reiter, R. J., & Manucha, W. A. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.888292 · Cited by 83
“Hence, a vicious circle between melatonin production levels and aging seems to exist, since melatonin synthesis decreases with the age and, at the same time, the aging is worsened as a consequence of the melatonin deficiency (Hardeland, 2019).”
BackgroundCheng, Z., Xiang, Q., Wang, J., & Zhang, Y. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101394 · Cited by 78
“The ability to synthesize melatonin in the body declines with age (Hardeland, 2019), indicating that it may be involved in age-related disorders.”
Bocheva, G., Bakalov, D. V., Iliev, P., & Tafradjiiska-Hadjiolova, R. K. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105122 · Cited by 268
“Overall, melatonin may act like either a pro-or anti-inflammatory molecule in different conditions [29,75].”
BackgroundLee, J. G., Woo, Y. S., Park, S. W., Seog, D., Seo, M. K., & Bahk, W. (2019) · Brain Sciences · doi:10.3390/brainsci9100285 · Cited by 81
“However, considering that the concentration of melatonin in the human body is lower than that of free radicals, it should be considered that melatonin may have an indirect antioxidant effect through the receptor mechanism, rather than direct antioxidant effects [36,37].”
BackgroundAutism spectrum disorder (ASD): Disturbance of the melatonin system and its implications
Wu, Z., Huang, S., Zou, J.-J., Wang, Q.-X., Naveed, M., Bao, H.-N., Wang, W., Fukunaga, K., & Han, F. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110496 · Cited by 82
Hardeland, R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22158296 · Cited by 71
“Importantly, there is a substantial overlap in the action spectra of melatonin and SIRT1 in the field of anti-inflammatory protection [4,23,74,113].”
BackgroundInfluentialSelf-citationInvolvement of the SIRT1-NLRP3 pathway in the inflammatory response
Chen, H., Deng, J., Gao, H., Song, Y., Zhang, Y., Sun, J., & Zhai, J. (2023) · Cell Communication and Signaling · doi:10.1186/s12964-023-01177-2 · Cited by 85
“SIRT1 is also controlled by various other factors, including accessory components of circadian oscillators that regulate nicotinamide phosphoribosyltransferase (NAMPT) expression and NAD + levels, such as triiodothyronine and glucocorticoids [56].”
BackgroundInfluentialControlling chronic low‐grade inflammation to improve follicle development and survival
Yang, Z., Tang, Z.-J., Cao, X., Xie, Q., Hu, C., Zhong, Z., Tan, J., & Zheng, Y. (2020) · American Journal of Reproductive Immunology · doi:10.1111/aji.13265 · Cited by 75
Redox Biology of Melatonin: Discriminating Between Circadian and Noncircadian Functions
Hardeland, R. (2022) · Antioxidants and Redox Signaling · doi:10.1089/ars.2021.0275 · Cited by 74
“Various others have been shown to stimulate or suppress NF-j B activation or SIRT1 signaling, however, in the absence of information on circadian control (105).”
InfluentialSelf-citationReiter, R. J., Sharma, R., Manucha, W. A., Rosales‐Corral, S., Chuffa, L. G. D. A., Loh, D., Luchetti, F., Balduini, W., & Govitrapong, P. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102480 · Cited by 84
“…molecular damage was induced by an extensive array of toxins (e.g., paraquat, ochratoxin, etc.), medications (ibuprofen, aspirin, prescription medications, etc.) or disease models (ischemia/reperfusion, Alzheimer ’ s disease models, etc.) (Hardeland, 2019; Joseph et al., 2024; Reiter et al., 2008).”
Chen, K., Tong, C., JingeYang, Cong, P., Liu, Y., Shi, X., Liu, X., Zhang, J., Zou, R., Xiao, K., et al. (2020) · Journal of Material Science and Technology · doi:10.1016/j.jmst.2020.06.001 · Cited by 66
Bacteriostatic Potential of Melatonin: Therapeutic Standing and Mechanistic Insights
He, F., Wu, X., Zhang, Q., Li, Y., Ye, Y., Li, P., Chen, S., Peng, Y., Hardeland, R., & Xia, Y. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683879 · Cited by 72
“Despite the emerging role of melatonin in fighting against bacterial infections, the protection mechanisms are only evident in the above-mentioned murine studies, plus additional anti-inflammatory effects that have been recently summarized (46, 63).”
BackgroundSelf-citationThe Role of Adaptogens in Prophylaxis and Treatment of Viral Respiratory Infections
Panossian, A., & Brendler, T. (2020) · Pharmaceuticals · doi:10.3390/ph13090236 · Cited by 73
Yasin, H. K., Taylor, A. H., & Ayakannu, T. (2021) · Cancers · doi:10.3390/cancers13092149 · Cited by 72
Bonomini, F., dos Santos, M., Veronese, F. V., & Rezzani, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20143466 · Cited by 63
“Recently, melatonin was reported to inhibit NLRP3 inflammasome [25].”
BackgroundClinical Trials for Use of Melatonin to Fight against COVID-19 Are Urgently Needed
Kleszczyński, K., Slominski, A. T., Steinbrink, K., & Reiter, R. J. (2020) · Nutrients · doi:10.3390/nu12092561 · Cited by 59
“The protective mechanisms by which melatonin acts, especially under conditions of high-grade inflammation and in aging, have been reviewed [4,5].”
BackgroundDiabetes mellitus and melatonin: Where are we?
Patel, R., PARMAR, N. R., Palit, S. P., RATHWA, N. N., Ramachandran, A. V., & Begum, R. (2022) · Biochimie · doi:10.1016/j.biochi.2022.01.001 · Cited by 65
Role of cytokines and reactive oxygen species in brain aging
MohanKumar, S. M. J., Murugan, A., Palaniyappan, A., & MohanKumar, P. S. (2023) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2023.111855 · Cited by 64
Melatonin/Nrf2/NLRP3 Connection in Mouse Heart Mitochondria during Aging
Fernández‐Ortiz, M., Sayed, R. K. A., Fernández‐Martínez, J., Cionfrini, A., Aranda‐Martínez, P., Escames, G., de Haro, T., & Acuña-Castroviejo, D. (2020) · Antioxidants · doi:10.3390/antiox9121187 · Cited by 60
“This brings about increased oxidative damage, chronodisruption, upregulation of pro-inflammatory cytokines, and downregulation of anti-oxidant/-inflammatory processes that contribute to inflammaging by facilitating mitochondrial disruption [45].”
BackgroundTan, D. X., Reiter, R. J., Zimmerman, S., & Hardeland, R. (2023) · Biology · doi:10.3390/biology12010089 · Cited by 64
Self-citationBrain washing and neural health: role of age, sleep, and the cerebrospinal fluid melatonin rhythm
Reiter, R. J., Sharma, R., Cucielo, M. S., Tan, D. X., Rosales‐Corral, S., Gancitano, G., & Chuffa, L. G. D. A. (2023) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-023-04736-5 · Cited by 59
Plant phenolics with promising therapeutic applications against skin disorders: A mechanistic review
Nisa, R. U., Nisa, A. U., Tantray, A. Y., Shah, A. H., Jan, A. T., Shah, A. A., & Wani, I. A. (2024) · Journal of Agriculture and Food Research · doi:10.1016/j.jafr.2024.101090 · Cited by 84
Toll-like receptor 4: An attractive therapeutic target for acute kidney injury
Jha, A. K., Gairola, S., Kundu, S., Doye, P., Syed, A. M., Ram, C., Murty, U. S., Naidu, V. G. M., & Sahu, B. D. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119155 · Cited by 58
Sirtuins: Research advances on the therapeutic role in acute kidney injury
Huang, C., Jiang, S., Gao, S., Wang, Y., Cai, X.-T., Fang, J., Yan, T., Wan, C. C., & Cai, Y. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154122 · Cited by 56
Farid, A., Moussa, P., Youssef, M., Haytham, M., Shamy, A., & Safwat, G. (2022) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2022.103313 · Cited by 55
“Hardeland (2019) found that decreased level of circulating melatonin was associated with losing the anti-oxidant protection and antiinflammatory effects.”
BackgroundJaworek, A., Szepietowski, J. C., Hałubiec, P., Wojas‐Pelc, A., & Jaworek, J. M. (2021) · Antioxidants · doi:10.3390/antiox10081179 · Cited by 56
“Studies on monocytes and T cells demonstrated that MT upregulated expression of proinflammatory cytokines, in particular IL-17, which subsequently initiates release of other interleukins (TNFα, IL-1β, IL-6) [83,86,87].”
BackgroundInflammatory Microenvironment Accelerates Bone Marrow Mesenchymal Stem Cell Aging
Peng, X., Zhou, X. H., Yin, Y., Luo, B., Liu, Y., & Yang, C. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.870324 · Cited by 55
“Regeneration can be restored by regulating the inflammatory environment with pharmacological compounds (Hardeland, 2019).”
BackgroundAndrade, M. K., Souza, L. C., de Azevedo, E. M., Bail, E. L., Zanata, S. M., Andreatini, R., & Vital, M. A. B. F. (2023) · IBRO Neuroscience Reports · doi:10.1016/j.ibneur.2023.01.005 · Cited by 54
“Another important aspect that may contribute to the non-decrease in GFAP levels refers to the immunostimulatory properties of melatonin, which seem to increase the production of some pro-inflammatory cytokines in some contexts (Hardeland, 2019).”
BackgroundDu, M., Sun, L., Guo, J. J., & Lv, H. (2024) · Pharmacological Research · doi:10.1016/j.phrs.2024.107198 · Cited by 57
Chen, C., Chen, C., Wang, S., Yeh, C., Su, S., Ueng, S., Chuang, W., Hsueh, C., & Wang, T. (2018) · Cancers · doi:10.3390/cancers10090320 · Cited by 49
SARS-CoV-2 Disease Adjuvant Therapies and Supplements Breakthrough for the Infection Prevention
Inchingolo, A. D., Inchingolo, A. M., Bordea, I. R., Malcangi, G., Xhajanka, E., Scarano, A., Lorusso, F., Farronato, M., Tartaglia, G. M., Isacco, C. G., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9030525 · Cited by 61
Morris, G., Puri, B. K., Walker, A. J., Maes, M. H. J., Carvalho, A. F., Walder, K. R., Mazza, C., & Berk, M. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104450 · Cited by 55
Skeletal muscle as an experimental model of choice to study tissue aging and rejuvenation
Etienne, J., Liu, C., Skinner, C. M., Conboy, M. J., & Conboy, I. M. (2020) · Skeletal Muscle · doi:10.1186/s13395-020-0222-1 · Cited by 60
Effects of sleep deprivation on anxiety-depressive-like behavior and neuroinflammation
Cao, D., Zhao, Y., Wang, Y., Wei, D., Yan, M., Su, S., Pan, H., & Wang, Q. (2024) · Brain Research · doi:10.1016/j.brainres.2024.148916 · Cited by 49
Melatonin and cancer suppression: insights into its effects on DNA methylation
Davoodvandi, A., Nikfar, B., Reiter, R. J., & Asemi, Z. (2022) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-022-00375-z · Cited by 52
“Interestingly, melatonin also has potent anti-inflammatory properties via reducing the expression levels of tumor necrosis factor alpha (TNF-α), interferon-gamma (IFN-γ), and interleukin-2 (IL-2) and by up-regulating the expression of anti-inflammatory cytokines such as, IL-4, IL-10, and IL-27 [15].”
BackgroundMelatonin, Its Metabolites and Their Interference with Reactive Nitrogen Compounds
Hardeland, R. (2021) · Molecules · doi:10.3390/molecules26134105 · Cited by 47
“Moreover, relationships have emerged between melatonin and proinflammatory microRNAs [239,252], some of which were recently shown to be downregulated in conjunction with the NLRP3 inflammasome [253].”
BackgroundSelf-citationMelatonin and the Skin: Current Progress and Perspectives for Human Health
Slominski, A. T., Kim, T., Janjetović, Z., Slominski, R. M., Ganguli‐Indra, G., Athar, M., Indra, A. K., Reiter, R. J., & Kleszczyński, K. (2025) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2024.11.012 · Cited by 51
Melatonin and alcohol-related disorders
Kurhaluk, N., & Ткаченко, Г. М. (2020) · Chronobiology International · doi:10.1080/07420528.2020.1761372 · Cited by 43
Yang, J., Liu, H., Han, S., Fu, Z., Wang, J., Chen, Y., & Wang, L. (2020) · The FASEB Journal · doi:10.1096/fj.202001252r · Cited by 44
Repurposing drugs to fight aging: The difficult path from bench to bedside
Vaiserman, A. M., Koliada, A. K., Lushchak, O. V., & Castillo, M. J. (2020) · Medicinal Research Reviews · doi:10.1002/med.21773 · Cited by 42
“effects of melatonin are those that are related to autophagy and regulation of energy metabolism, including insulin/ IGF‐1 pathway, phosphoinositide‐3‐kinase–protein kinase B/Akt (PI3K‐PKB/Akt) pathway, mTOR pathway,(197) and also SIRT1.(198) All of these pathways are known to be essentially contributed to aging and a…”
BackgroundInfluentialThe 15-Months Clinical Experience of SARS-CoV-2: A Literature Review of Therapies and Adjuvants
Inchingolo, A. D., Dipalma, G., Inchingolo, A. M., Malcangi, G., Santacroce, L., D’Oria, M. T., Isacco, C. G., Bordea, I. R., Candrea, S., Scarano, A., et al. (2021) · Antioxidants · doi:10.3390/antiox10060881 · Cited by 60
Melatonin: highlighting its use as a potential treatment for SARS-CoV-2 infection
Reiter, R. J., Sharma, R., Šimko, F., Domínguez‐Rodríguez, A., Tesařík, J., Neel, R. L., Slominski, A. T., Kleszczyński, K., Martin-Gimenez, V. M., Manucha, W. A., et al. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-021-04102-3 · Cited by 42
Bai, A., Shi, H., Huang, X., Xu, W., & Deng, Y. (2021) · The journal of nutrition health & aging · doi:10.1007/s12603-021-1678-3 · Cited by 43
Melatonin prevents oxidative stress, inflammatory activity, and DNA damage in cirrhotic rats
Colares, J. R., Hartmann, R. M., Schemitt, E. G., da Fonseca, S. R. B., Brasil, M. D. S., Picada, J. N., Dias, A. S., Bueno, A. F., Marroni, C. A., & Marroni, N. P. (2022) · World Journal of Gastroenterology · doi:10.3748/wjg.v28.i3.348 · Cited by 42
Liu, H., Ren, M., Li, Y., Zhang, R., Ma, N., Li, T., Jiang, W., Zhou, Z. Y., Yao, X., Liu, Z., et al. (2022) · Free Radical Research · doi:10.1080/10715762.2022.2037580 · Cited by 41
“The main function of melatonin is to regulate the circadian rhythm, but it also has anti-aging, anti-oxidation, anti-inflammatory, anti-apoptotic, and reproductive functions [14].”
BackgroundMerlo, S., Luaces, J. P., Spampinato, S. F., Toro-Urrego, N., Caruso, G. I., D’Amico, F., Capani, F., & Sortino, M. A. (2020) · Biomolecules · doi:10.3390/biom10030364 · Cited by 42
Pineal hormone melatonin as an adjuvant treatment for COVID-19 (Review)
Vlachou, M., Siamidi, A., Dedeloudi, A., Konstantinidou, S., & Papanastasiou, I. P. (2021) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2021.4880 · Cited by 27
“A number of these actions are mediated by its MT1 and MT2 receptors (37,51).”
BackgroundAlizadeh, Z., Keyhanian, N., Ghaderkhani, S., Dashti‐Khavidaki, S., Shoormasti, R. S., & Pourpak, Z. (2021) · Iranian Journal of Allergy Asthma and Immunology · doi:10.18502/ijaai.v20i4.6959 · Cited by 43
Ameliorative effects of topical ramelteon on imiquimod-induced psoriasiform inflammation in mice
Khafaji, A. W. M., Al-Zubaidy, A. A., Farhood, I. G., & Salman, H. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03017-7 · Cited by 38
“…with Hard-eland’s (2019) findings, which demonstrated that proinflammatory cytokines, including TNF-α, IFNγ, IL-1β, IL-2, IL-6, IL-12, and monocyte-derived cell lines, have been frequently reported to be elevated in response to melatonin in monocytes and type 1 T-helper cells (Hardeland 2019).”
Thymus-Pineal Gland Axis: Revisiting Its Role in Human Life and Ageing
Rezzani, R., Franco, C., Hardeland, R., & Rodella, L. F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21228806 · Cited by 52
Self-citationWang, Y., Xing, C., Zhang, H., Pan, Z., & Sun, S. (2021) · Biology of Reproduction · doi:10.1093/biolre/ioab171 · Cited by 36
Gao, Z., Luo, K., Hu, Y., Niu, Y., Zhu, X., Li, S., & Zhang, H. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02887-y · Cited by 42
Tonev, D. G., & Momchilova, A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242417223 · Cited by 37
Effects of melatonin on protecting against lung injury (Review)
Wang, W., & Gao, J. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.9659 · Cited by 42
Yang, L., Cheng, J., Xu, D., Zhang, Z., Hua, R., Chen, H., Duan, J., Li, X., & Li, Q. (2023) · Toxics · doi:10.3390/toxics11020160 · Cited by 36
“Furthermore, several melatonin-related effects can be abolished via SIRT1 inhibition, indicating potential mediation by SIRT1 in non-tumor cells [60].”
BackgroundCaruso, G. I., Spampinato, S. F., Costantino, G., Merlo, S., & Sortino, M. A. (2021) · Biomedicines · doi:10.3390/biomedicines9050466 · Cited by 38
“It has been pointed out that SIRT1 activity may be hampered depending on local NAD+ availability [69].”
BackgroundChen, J., Zhang, L., Du, H., Zhan, C., Liu, Y., Zhang, M., Chen, X., Wen, L., Zhang, L., & Liang, C. Y. (2021) · The Prostate · doi:10.1002/pros.24214 · Cited by 35
“It can suppress inflammation‐promoting factors, such as NO and proinflammatory cytokines release, cyclooxygenase‐2 and gasdermin D activation, and participate in the Toll‐like receptor‐4 and mTOR signaling pathways.(19) Notably, recent studies have demonstrated that melatonin could attenuate the inflammatory response…”
BackgroundInfluentialMelatonin as a promising modulator of aging related neurodegenerative disorders: Role of microRNAs
Fathalizadeh, A., Rahnemayan, S., Rajabi, H., Vahed, N., Kashani, H. R. K., Rezabakhsh, A., & Sanaie, S. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2021.105839 · Cited by 34
Therapeutic potential of melatonin and melatonergic drugs on K18‐hACE2 mice infected with SARS‐CoV‐2
Cecon, E., Izabelle, C., Poder, S. L., Real, F., Zhu, A., Tu, L., Ghigna, M., Klonjkowski, B., Bomsel, M., Jockers, R., et al. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12772 · Cited by 33
Sirtuins in macrophage immune metabolism: A novel target for cardiovascular disorders
Xu, C.-Q., Li, J., Liang, Z., Zhong, Y.-L., Zhang, Z., Hu, X., Cao, Y., & Chen, J. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.128270 · Cited by 33
Roth‐Walter, F., Adcock, I. M., Benito‐Villalvilla, C., Bianchini, R., Bjermer, L. H., Caramori, G., Cari, L., Chung, K. F., Diamant, Z., Eguíluz‐Gracia, I., et al. (2023) · Allergy · doi:10.1111/all.15977 · Cited by 35
Melatonin and Vascular Function
Mendes, L., Queiroz, M., & Sena, C. M. (2024) · Antioxidants · doi:10.3390/antiox13060747 · Cited by 42
“Similarly, this indoleamine promotes the polarization of macrophages from a proinflammatory phenotype (M1 phenotype) to an anti-inflammatory phenotype (M2 phenotype) and stimulates the release of anti-inflammatory cytokines such as IL-4 and IL-10 [17].”
BackgroundInfluentialMelatonin in Wine and Beer: Beneficial Effects
Marhuenda, J., Villaño, D., Arcusa, R., & Zafrilla, P. (2021) · Molecules · doi:10.3390/molecules26020343 · Cited by 31
“Moreover, MEL is capable of capturing reactive oxygen species, such as peroxynitrite [8] and even hydrogen peroxide in a dose-dependent way [9], as well as demonstrating antioxidant capacity in vitro through the ABTS+ method [10].”
MethodThe Beneficial Role of Sirtuin 1 in Preventive or Therapeutic Options of Neurodegenerative Diseases
Liu, H., Xu, S., Wang, C., Deng, Y. L., Xu, B., Yang, T., Sun, J., & Liu, W. (2022) · Neuroscience · doi:10.1016/j.neuroscience.2022.09.021 · Cited by 32
Riviere, E., Rossi, S. P., Tavalieri, Y. E., Muñoz‐de‐Toro, M., Ponzio, R., Puigdomenech, E., Levalle, O. A., Martinez, G., Terradas, C., Calandra, R. S., et al. (2020) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2020.110889 · Cited by 32
Melatonin to Rescue the Aged Heart: Antiarrhythmic and Antioxidant Benefits
Segovia‐Roldán, M., Diez, E. R., & Pueyo, E. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/8876792 · Cited by 34
Wu, J., Hao, Z., Wang, Y., Yan, D., Meng, J., & Ma, H. (2022) · Food and Chemical Toxicology · doi:10.1016/j.fct.2022.113561 · Cited by 33
Pangrazzi, L., & Meryk, A. (2024) · Biology · doi:10.3390/biology14010017 · Cited by 40
“Anti-inflammatory Actions: Melatonin suppresses the production of pro-inflammatory cytokines and modulates the activity of immune cells, contributing to the attenuation of inflammaging [58].”
Sahu, P., & Satapathy, T. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01867-y · Cited by 35
“In chronic or aged tissues, sustained SASP signaling can become detrimental, leading to immune cell exhaustion, skewing macrophages toward an anti-inflammatory M2 phenotype, and impairing the activity of cytotoxic T lymphocytes (Hardeland 2019).”
Liraglutide ameliorates lipotoxicity-induced inflammation through the mTORC1 signalling pathway
Ao, N., Ma, Z., Yang, J., Jin, S., Zhang, K., Luo, E., & Du, J. (2020) · Peptides · doi:10.1016/j.peptides.2020.170375 · Cited by 30
Perspective Adjunctive Therapies for COVID-19: Beyond Antiviral Therapy
Ho, P., Zheng, J.-Q., Wu, C., Hou, Y., Liu, W.-C., Lu, C., Zheng, C., Lu, K., & Chao, Y. (2020) · International Journal of Medical Sciences · doi:10.7150/ijms.51935 · Cited by 31
“Since lower plasma melatonin concentration is noted in individuals at approximately age 60, in males and in different comorbid conditions [7, 107, 108], the susceptibility of these populations to severe COVID-19 might be related to their increased melatonin requirement.”
BackgroundCell Senescence and Central Regulators of Immune Response
Lunin, S. M., Novoselova, E. G., Glushkova, O. V., Parfenyuk, S. B., Novoselova, T. V., & Khrenov, M. O. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084109 · Cited by 31
Li, N., Zhai, K., Yin, Q., Gu, Q., Zhang, X., Melencion, M. G., & Chen, Z. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1143511 · Cited by 48
“For example, melatonin modulates sleep and circadian rhythms, enhances immunity and antiinflammatory activities (23, 24).”
Background
Metadata
- Authors
- Hardeland, R.
- Affiliations
- University of Göttingen (DE)
- Corresponding author
- Hardeland, Rüdiger
- ORCID
- Hardeland, Rüdiger
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-03-11
- Volume
- 20
- Issue
- 5
- Pages
- 1223
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6429360
- OpenAlex
- W2922219401
- Cited by
- 337
- References
- 412
- Citations by year
- 2026: 21 · 2025: 50 · 2024: 49 · 2023: 52 · 2022: 55 · 2021: 53 · 2020: 46 · 2019: 9
- FWCI
- 4.90
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- GoeScholar The Publication Server of the Georg-August-Universität Göttingen (Georg-August-Universität Göttingen) (submittedVersion, cc-by)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Circadian rhythm and melatonin
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- melatonin, aging, inflammation, SIRT1, circadian rhythm, inflammatory cytokines, anti-inflammatory cytokines, Nrf2, NF-κB, M2 macrophage polarization, microglia, microRNA, senescence-associated secretory phenotype, NLRP3 inflammasome, gasdermin D, TLR4, mTOR signaling, amyloid-beta toxicity, age-related diseases
- MeSH terms
- Aging, Animals, Disease Susceptibility, Gene Expression Regulation, Humans, Inflammation, Melatonin, Signal Transduction, Biomarkers, Cytokines, Inflammation Mediators, Gene Regulatory Networks, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.